WallStSmart

BrightSpring Health Services, Inc. Common Stock (BTSG)vsCertara Inc (CERT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

BrightSpring Health Services, Inc. Common Stock generates 3308% more annual revenue ($14.37B vs $421.75M). BTSG leads profitability with a 2.5% profit margin vs -16.2%. BTSG earns a higher WallStSmart Score of 55/100 (C).

BTSG

Buy

55

out of 100

Grade: C

Growth: 8.7Profit: 5.0Value: 4.0Quality: 6.0
Piotroski: 5/9Altman Z: 2.59

CERT

Avoid

31

out of 100

Grade: F

Growth: 4.0Profit: 2.5Value: 6.7Quality: 7.0
Piotroski: 5/9Altman Z: 1.63
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BTSG.

CERTUndervalued (+54.4%)

Margin of Safety

+54.4%

Fair Value

$15.21

Current Price

$7.55

$7.66 discount

UndervaluedFair: $15.21Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BTSG2 strengths · Avg: 9.0/10
EPS GrowthGrowth
196.6%10/10

Earnings expanding 196.6% YoY

Revenue GrowthGrowth
23.0%8/10

Revenue surging 23.0% year-over-year

CERT1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Areas to Watch

BTSG4 concerns · Avg: 2.8/10
Profit MarginProfitability
2.5%3/10

2.5% margin — thin

Operating MarginProfitability
3.4%3/10

Operating margin of 3.4%

Debt/EquityHealth
1.173/10

Elevated debt levels

P/E RatioValuation
54.2x2/10

Premium valuation, high expectations priced in

CERT4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
1.0%4/10

1.0% revenue growth

Altman Z-ScoreHealth
1.634/10

Distress zone — elevated risk

Market CapQuality
$1.18B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-1.5%2/10

ROE of -1.5% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : BTSG

The strongest argument for BTSG centers on EPS Growth, Revenue Growth. Revenue growth of 23.0% demonstrates continued momentum.

Bull Case : CERT

The strongest argument for CERT centers on Price/Book.

Bear Case : BTSG

The primary concerns for BTSG are Profit Margin, Operating Margin, Debt/Equity. A P/E of 54.2x leaves little room for execution misses. Thin 2.5% margins leave little buffer for downturns.

Bear Case : CERT

The primary concerns for CERT are Revenue Growth, Altman Z-Score, Market Cap.

Key Dynamics to Monitor

BTSG profiles as a growth stock while CERT is a turnaround play — different risk/reward profiles.

BTSG carries more volatility with a beta of 1.85 — expect wider price swings.

BTSG is growing revenue faster at 23.0% — sustainability is the question.

BTSG generates stronger free cash flow (15M), providing more financial flexibility.

Bottom Line

BTSG scores higher overall (55/100 vs 31/100) and 23.0% revenue growth. CERT offers better value entry with a 54.4% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BrightSpring Health Services, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, focusing on diverse patient populations, including individuals with intellectual and developmental disabilities and those in need of rehabilitation support. The company prioritizes personalized, high-quality care, facilitated by a dedicated and skilled workforce that significantly improves patient outcomes and quality of life. With robust investments in innovative technologies and a strong commitment to value-based care, BrightSpring is well-positioned to capitalize on growth opportunities within the dynamic healthcare landscape, highlighting its potential for sustainable, long-term success.

Visit Website →

Certara Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Certara Inc. provides software products and technology services to clients for biosimulation in drug discovery, preclinical and clinical research, regulatory filings, and market access. The company is headquartered in Princeton, New Jersey.

Want to dig deeper into these stocks?